In The News Posted October 1, 2021 Share Posted October 1, 2021 HOLON, Israel, Oct. 1, 2021 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that new clinical and preclinical data will be presented at the 36th Annual Meeting of the Society for...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts